Simulated Quantum Annealing Ranked Known Drug Pairs First for Diabetes and Rheumatoid Arthritis: Ramos, Coutinho and Magano in Quantum Machine Intelligence, 23 June 2026

Quentir Medicine Monitor

Evidence-based insights for quantum medicine.

Three researchers from Porto and the German Aerospace Center have written drug-pair selection as an energy problem that a quantum annealer could solve, and tested it on diabetes, rheumatoid arthritis, asthma and brain tumors. In simulation, the lowest-energy answers were dominated by drug combinations that doctors already use, and one of the top new suggestions for rheumatoid arthritis matches a pairing that a 799-patient trial found to roughly double remission rates.

The paper, by Diogo Ramos, Bruno Coutinho and Duarte Magano, appeared open access in Quantum Machine Intelligence on 23 June 2026 as article 70 of volume 8. It builds on the Complementary Exposure idea from network medicine, turns it into an optimization problem, and samples answers with simulated quantum annealing, a classical computer program that imitates how quantum annealing hardware behaves. Its central test is how often validated drug combinations appear among the top-ranked answers when they make up less than a tenth of a percent of the candidates.

Combination therapy is standard across chronic disease and oncology, because two drugs together can allow lower doses and fewer side effects. The search space is the problem. With more than a thousand approved drugs and thousands of diseases, the number of possible pairs grows far faster than any laboratory or trial program can test them.

For a pharmacology team or a hospital formulary committee, the study offers a clear example of what quantum optimization can and cannot yet contribute to that search. The ranking method works in simulation on four diseases. No quantum computer was used, and the authors state plainly that their predictions are hypotheses for experts to examine.